المؤلفون: Chrysanthi Kouri, Grit Sommer, Idoia Martinez de Lapiscina, Rawda Naamneh Elzenaty, Lloyd J.W. Tack, Martine Cools, S. Faisal Ahmed, Christa E. Flück, Saygin Abali, Zehra Yavas Abali, Leyla Akin, Maricruz Almaraz, Laura Audí, Murat Aydin, Antonio Balsamo, Federico Baronio, Jillian Bryce, Kanetee Busiah, Maria Caimari, Núria Camats-Tarruella, Ariadna Campos-Martorell, Luis Castaño, Anna Casteràs, Semra Çetinkaya, Yee-Ming Chan, Hedi L. Claahsen-van der Grinten, Ines Costa, Fatma Feyza Darendeliler, Justin H. Davies, Isabel Esteva, Helena Fabbri-Scallet, Courtney A. Finlayson, Emilio Garcia, Beatriz Garcia Cuartero, Alina German, Evgenia Globa, Gil Guerra-Junior, Julio Guerrero, Tulay Guran, Sabine E. Hannema, Olaf Hiort, Josephine Hirsch, Leuan Hughes, Marco Janner, Zofia Kolesinska, Katherine Lachlan, Anna Lauber-Biason, Jana Krenek Malikova, Dagmar l'Allemand, Nina Lenhnerr-Taube, Angela Lucas-Herald, Jamala Mammadova, Kenneth MсElreavey, Veronica Mericq, Isabel Mönig, Francisca Moreno, Julia Mührer, Marek Niedziela, Anna Nordenstrom, Burçe Orman, Sukran Poyrazoglu, Jose M. Rial, Meilan M. Rutter, Amaia Rodríguez, Tara Schafer-Kalkhoff, Kay-Sara Sauter, Sumudu Nimali Seneviratne, Maria Sredkova-Ruskova, Rieko Tadokoro-Cuccaro, Ajay Thankamony, Mónica Tomé, Amaia Vela, Malgorzata Wasniewska, David Zangen, Nataliya Zelinska

المصدر: EBioMedicine, Vol 99, Iss , Pp 104941- (2024)

مصطلحات موضوعية: Steroidogenic factor 1 (SF-1/NR5A1), Differences of sex development (DSD), Broad phenotype, Genetics of sex determination and differentiation, Intersex, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2352396423005078Test; https://doaj.org/toc/2352-3964Test

الوصول الحر: https://doaj.org/article/85fc4633ac7a47e48fff5e498c208fd3Test

المؤلفون: Houzelstein, Denis, Eozenou, Caroline, Lagos, Carlos F, Elzaiat, Maëva, Bignon-Topalovic, Joelle, Gonzalez, Inma, Laville, Vincent, Schlick, Laurène, Wankanit, Somboon, Madon, Prochi, Kirtane, Jyotsna, Athalye, Arundhati, Buonocore, Federica, Bigou, Stéphanie, Conway, Gerard S, Bohl, Delphine, Achermann, John C, Bashamboo, Anu, McElreavey, Ken

المصدر: Nat Commun , 15 (1) , Article 2796. (2024)

مصطلحات موضوعية: Animals, Female, Humans, Male, Cell Line, Gonadal Dysgenesis, Mammals, Regulatory Sequences, Nucleic Acid, Sertoli Cells, Sex-Determining Region Y Protein, Steroidogenic Factor 1, Testis

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10190309Test/1/s41467-024-47162-2.pdf; https://discovery.ucl.ac.uk/id/eprint/10190309Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10190309Test/1/s41467-024-47162-2.pdf
https://discovery.ucl.ac.uk/id/eprint/10190309Test/

المؤلفون: Hande Turan, Gürkan Tarçın, Özgür Mete, Ada Bulut Sinoplu, Saadet Olcay Evliyaoğlu, Büge Öz, Oya Ercan

المصدر: JCRPE, Vol 14, Iss 1, Pp 126-130 (2022)

مصطلحات موضوعية: adrenocortical choristoma, corticotroph adenoma, steroidogenic factor 1, Pediatrics, RJ1-570, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://jag.journalagent.com/z4/download_fulltext.asp?pdir=jcrpe&un=JCRPE-08370Test; https://doaj.org/toc/1308-5735Test

الوصول الحر: https://doaj.org/article/0f2dc468a88546eba3f2cdda78669d3aTest

المؤلفون: Relav, Lauriane, Doghman-Bouguerra, Mabrouka, Ruggiero, Carmen, Muzzi, João, C D, Figueiredo, Bonald, C, Lalli, Enzo

المساهمون: Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (1965 - 2019) (UNS)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UniCA), Instituto de Pesquisa Pelé Pequeno Principe, ANR-20-CE14-0007,Goldilocks,Analyse intégrée du rôle du facteur de transcription SF-1 / NR5A1 et de ses gènes cibles dépendants du dosage dans la fonction gonadique et les troubles du développement sexuel (DSD)(2020)

المصدر: ISSN: 1661-6596.

مصطلحات موضوعية: Steroidogenic Factor 1, transcription factors, nuclear receptors, adrenal cortex, steroidogenesis, gene dosage, tumorigenesis, adrenocortical carcinoma, [SDV]Life Sciences [q-bio]

العلاقة: hal-04195897; https://hal.science/hal-04195897Test; https://hal.science/hal-04195897/documentTest; https://hal.science/hal-04195897/file/IJMS%202023.pdfTest

الإتاحة: https://doi.org/10.3390/ijms24043585Test
https://hal.science/hal-04195897Test
https://hal.science/hal-04195897/documentTest
https://hal.science/hal-04195897/file/IJMS%202023.pdfTest

المؤلفون: Olga Glazova, Asya Bastrich, Andrei Deviatkin, Nikita Onyanov, Samira Kaziakhmedova, Liudmila Shevkova, Nawar Sakr, Daria Petrova, Maria V. Vorontsova, Pavel Volchkov

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 6; Pages: 5365

مصطلحات موضوعية: adrenal cortex, cell differentiation, steroidogenic factor 1, CAH, organoids, murine models, single cell RNA sequencing

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Molecular Pathology, Diagnostics, and Therapeutics; https://dx.doi.org/10.3390/ijms24065365Test

الإتاحة: https://doi.org/10.3390/ijms24065365Test

المؤلفون: Lauriane Relav, Mabrouka Doghman-Bouguerra, Carmen Ruggiero, João C. D. Muzzi, Bonald C. Figueiredo, Enzo Lalli

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 4; Pages: 3585

مصطلحات موضوعية: steroidogenic factor 1, transcription factors, nuclear receptors, adrenal cortex, steroidogenesis, gene dosage, tumorigenesis, adrenocortical carcinoma

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Molecular Oncology; https://dx.doi.org/10.3390/ijms24043585Test

الإتاحة: https://doi.org/10.3390/ijms24043585Test

المؤلفون: D. P. Yashina, Z. A. Afanasyeva, Д. П. Яшина, З. А. Афанасьева

المساهمون: Figure was partially generated using Servier Medical Art provided by Servier, licensed under a Creative Commons Attribution 3.0 non-ported license., В рисунках использованы элементы шаблонов Servier Medical Art, предоставленные компанией Servier с лицензией Creative Commons Attribution 3.0.

المصدر: Advances in Molecular Oncology; Том 10, № 2 (2023); 42-57 ; Успехи молекулярной онкологии; Том 10, № 2 (2023); 42-57 ; 2413-3787 ; 2313-805X ; 10.17650/2313-805X-2023-10-2

مصطلحات موضوعية: miRNA, adrenal ontogenesis, tumor transformation, signaling pathways, steroidogenic factor 1, Sonic Hedgehog, signaling pathways Wnt/β-catenin, signaling pathway SMAD, growth factors, insulin-like growth factor 2, transforming growth factor β, онтогенез надпочечников, опухолевая трансформация, сигнальные пути, стероидный фактор 1, сигнальный путь Wnt/β-катенин, сигнальный путь SMAD, факторы роста, инсулиноподобный фактор роста 2, трансформирующий фактор роста β

وصف الملف: application/pdf

العلاقة: https://umo.abvpress.ru/jour/article/view/540/299Test; Else T., Kim A.C., Sabolch A. et al. Adrenocortical carcinoma. Endocrine Rev 2014;35(2):282–326. DOI:10.1210/er.2013-1029; Pittaway J., Guasti L. Pathobiology and genetics of adrenocortical carcinoma. Mol Endocrinol 2020;62(2):105–19. DOI:10.1530/JME-18-0122; Doghman M., Karpova T., Rodrigues G. et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007;21(12):2968–987. DOI:10.1210/me.2007-01204; Bronswijk M.J.H., Laenen A., Bechter O.E. Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: a single center experience. Neoplasma 2020;67(1): 209–3. DOI:10.4149/neo_2019_190105N17; Ettaieb M., Kerkhofs T., van Engeland M., Haak H. Past, present and future of epigenetics in adrenocortical carcinoma. Cancers (Basel) 202013;12(5):1218. DOI:10.3390/cancers12051218; Mizdrak M., Tičinović Kurir T., Božić J. The role of biomarkers in adrenocortical carcinoma: a review of current evidence and future perspectives. Biomedicines 2021;9(2):174. DOI:10.3390/biomedicines9020174; Кроненберг Г.M., Рид Л., Полонский К. и др. Эндокринология по Вильямсу. Заболевания коры надпочечников и эндокринная артериальная гипертензия. М.: ГЭОТАР-Медиа, 2010. 208 с.; Simon D.P., Hammer G.D. Adrenocortical stem and progenitor cells: implications for adrenocortical carcinoma. Mol Cell Endocrinol 2012;351(1):2–11. DOI:10.1016/j.mce.2011.12.006; Walczak E.M., Hammer G.D. Regulation of the adrenocortical stem cell niche: implications for disease. Nat Rev Endocrinol 2015;11(1):14–28. DOI:10.1016/j.mce.2011.12.006; Xing Y., Lerario A.M., Rainey W., Hammer G.D. Development of adrenal cortex zonation. Endocrinol Metab Clin North Am 2015;44(2):243–74. DOI:10.1016/j.ecl.2015.02.001; Gummow B.M., Sheys J.O., Canselli V.R. et al. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol 2006;20(11):2711–23. DOI:10.1210/me.2005-0461; Gut P., Huber K., Lohr J. et al. Lack of an adrenal cortex in Sf1 mutant mice is compatible with the generation and differentiation of chromaffin cells. Development 2005;132(20):4611–9. DOI:10.1242/dev.02052; Bland M., Fowkes R.C., Ingraham H.A. Differential requirement for steroidogenic factor-1 gene dosage in adrenal development versus endocrine function. Mol Endocrinol 2004;18(4):941–52. DOI:10.1210/me.2003-0333; Walczak E.M., Kuick R., Finco I. et al. Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms. Mol Endocrinol 2014;28(9):1471–86. DOI:10.1210/me.2014-1060; Исаева А.В., Зима А.П., Шабалова И.П. и др. β-катенин: структура, функции и роль в опухолевой трансформации эпителиальных клеток. Вестник РАМН 2015;70(4):475–83. DOI:10.15690/vramn; Hazell G., Horn G., Lightman S.L. et al. Dynamics of ACTH-mediated regulation of gene transcription in ATC1 and ATC7 adrenal zona fasciculata cell lines. Endocrinology 2019;160(3):587–604. DOI:10.1210/en.2018-00840; Pitsava G., Maria A.G., Faucz F.R. Disorders of the adrenal cortex: genetic and molecular aspects. Front Endocrinol (Lausanne) 2022;13:931389. DOI:10.3389/fendo.2022.931389; Belogorsky A., Baquedano M.S., Guercio G. et al. Adrenarche: postnatal adrenal zonation and hormonal and metabolic regulation. Horm Res 2008;70:257–67. DOI:10.1159/000157871; King P., Paul A., Laufer E. SHH signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. Proc Natl Acad Sci USA 2009;106(50):21185–90. DOI:10.1073/pnas.0909471106; Finco I., Lerario A.M., Hammer G.D. Sonic hedgehog and WNT signaling promote adrenal gland regeration in male mice. Endocrinology 2018;159(2):579–96. DOI:10.1210/en.2017-03061; Gummow B.M., Scheys J.O., Cancelli V.R. et al. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol 2006;20(11):2711–23. DOI:10.1210/me.2005-0461; Abou Nader N., Zamberlam G., Boyer A. Transgenic mouse models to study the development and maintenance of the adrenal cortex. Int J Mol Sci 2022;23(22):14388. DOI:10.3390/ijms232214388; Maity P., Mondal A., Das R. et al. Diagnostic and prognostic utility of SF-1 in adrenal cortical tumours. Indian J Pathol Microbiol 2022;65(4):814–20. DOI:10.4103/ijpm.ijpm_153_21; Muzzi J.C.D., Magno J.M., Souza J.S. et al. Comprehensive characterization of the regulatory landscape of adrenocortical carcinoma: novel transcription factors and targets associated with prognosis. Cancers (Basel) 2022;14(21):5279. DOI:10.3390/cancers14215279; Ткачук А.В., Бельцевич Д.Г., Порубаева Э.Э., Урусова Л.С. Морфологические предикторы эффективности терапии митотаном при адренокортикальном раке. Проблемы эндокринологии 2022;68(6):76–88. DOI:10.14341/probl13172; Черепанов С.А., Баклаушев В.П., Габашвили А.Н. и др. Hedgehog-сигналинг и его роль в патогенезе нейроонкологических заболеваний. Биомедицинская химия 2015;61(3): 332–42. DOI:10.18097/PBMC20156103332; Бяхова М.М., Воронкова И.А., Кривошеев А.В. Молекулярно-генетические характеристики адренокортикального рака. Русский медицинский журнал 2017;22:1651–3.; Геннадиник А.Г., Нелаева А.А. Роль инсулиноподобного фактора роста-I в метаболизме, регуляции клеточного обновления и процессах старения. Ожирение и метаболизм 2010; 2:10–6.; Костылева О.И., Герштейн Е.С., Ермилова В.Д. и др. Инсулиноподобные факторы роста I и II в сыворотке крови больных раком молочной железы. Вестник ТГУ 2014;19(1):16–20.; Шевченко В.Е., Брюховецкий И.С., Никифорова З.Н. и др. Трансформирующий фактор роста бета-1 в онкогенезе аденокарциномы легкого человека. Успехи молекулярной онкологии 2017;4(4):67–74. DOI:10.17650/2313-805X-2017-4-3-67-74; Neel J.Ch., Humbert L., Lebrun J.J. et al. The dual role of TGF β in human cancer: from tumor suppression to cancer metastasis. ISRN Mol Biol 2012;2012:381428. DOI:10.5402/2012/381428; Pereira S.S., Oliveira S., Monteiro M.P., Pignatelli D. Angiogenesis in the normal adrenal fetal cortex and adrenocortical tumors. Cancers (Basel) 2021;13(5):1030. DOI:10.3390/cancers1305103; Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2011;2(12):1097–105. DOI:10.1177/1947601911423031; Liggins G.C. Adrenocortical-related maturational events in the fetus. Am J Obstet Gynecol 1976;126(7):93141. DOI:10.1016/0002-9378(76)90680-3; Kolomecki K., Stepien H., Bartos M., Kuzdak K. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours. Endocr Regul 2001;35(1):9–16.; Zacharieva S., Atanassova I., Orbetzova M. et al. Circulating vascular endothelial growth factor and active renin concentrations and prostaglandin E2 urinary excretion in patients with adrenal tumours. Eur J Endocrinol 2004;150(3):345–9. DOI:10.1530/eje.0.1500345; Bernini G.P., Moretti A., Bonadio A.G. et al. Angiogenesis in human normal and pathologic adrenal cortex. J Clin Endocrinol Metab 2002;87(11):4961–5. DOI:10.1210/jc.2001-011799; Kroiss M., Reuss M., Kühner D. et al. Sunitinib inhibits cell proliferation and alters steroidogenesis by down-regulation of HSD3B2 in adrenocortical carcinoma cells. Front Endocrinol (Lausanne) 2011;2:27. DOI:10.3389/fendo.2011.00027; De Fraipont F., El Atifi M., Gicquel C. et al. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations. J Clin Endocrinol Metab 2000;85(12): 4734–41. DOI:10.1210/jcem.85.12.7012; Xu Y.Z., Zhu Y., Shen Z.J. et al. Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy. Endocrine 2011;40(3):445–51. DOI:10.1007/s12020-011-9502-1; Pozdeyev N., Fishbein L., Gay L.M. et al. Targeted genomic analysis of 364 adrenocortical carcinomas. Endocr Relat Cancer 2021;28(10):671–81. DOI:10.1530/ERC-21-0040; Silvestri E., Lombardi A., De Lange P. et al. Studies of complex biological systems with applications in molecular medicine: the need for integration of transcriptomic and proteomic approaches. J Biomed Biotechnol 2011;2011:810242.; Detomas M., Pivonello C., Pellegrini B. et al. MicroRNAs and long non-coding RNAs in adrenocortical carcinoma. Cells 2022;11(14):2234. DOI:10.3390/cells11142234; Decmann A., Perge P., Turai P.I. et al. Non-coding RNAs in adrenocortical cancer: from pathogenesis to diagnosis. Cancers 2020;12(2):461. DOI:10.3390/cancers12020461; Koperski Ł., Kotlarek M., Świerniak M. et al. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy. Oncotarget 2017;8(30):49191–200.; Kwok G.T.Y., Zhao J.T., Glover A.R. et al. microRNA-431 as a chemosensitizer and potentiator of drug activity in adreno-cortical сarcinoma. Oncologist 2019;24(6):e241–50. DOI:10.1634/theoncologist.2018-0849; Wang S., Li M.Y., Liu Y. et al. The role of microRNA in cisplatin resistance or sensitivity. Expert Opin Ther Targets 2020;24:885–97. DOI:10.1080/14728222.2020.1785431; Turai P.I., Herold Z., Nyirő G. et al. Tissue miRNA combinations for the differential diagnosis of adrenocortical carcinoma and adenoma established by artificial intelligence. Cancers (Basel) 2022;14(4):895. DOI:10.3390/cancers14040895; Ye B., Shi J., Kang H. et al. Advancing pan-cancer gene expression survial analysis by inclusion of non-coding RNA. RNA Biol 2020;17(11):1666–73. DOI:10.1080/15476286.2019; Darabi S., Braxton D.R., Eisenberg B.L., Demeure M.J. Molecular genomic profiling of adrenocortical cancers in clinical practice. Surgery 2021;169(1):138–44. DOI:10.1016/j.surg.2020.05.039; Arlt W., Biehl M., Taylor A.E. et al. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J Clin Endocrinol Metab 2011;96(12):3775–84. DOI:10.1210/jc.2011-1565; Uchida T., Nishimoto K., Fukumura Y. et al. Disorganized steroidogenesis in adrenocortical carcinoma, a case study. Endocr Pathol 2017;28(1):27–35. DOI:10.1007/s12022-016-9441-8; Sasano H., Miyazaki S., Sawai T. et al. Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases. Mod Pathol 1992;5(1):23–9.; Hou Y., Gao Y., Guo S. et al. Applications of spatially resolved omics in the field of endocrine tumors. Front Endocrinol (Lausanne) 2023;13:993081. DOI:10.3389/fendo.2022.993081; Bothou C., Penton D., Abate A. et al. A comprehensive investigation of steroidogenic signaling in classical and new experimental cell models of adrenocortical carcinoma. Cells 2022;11(9):1439. DOI:10.3390/cells11091439; Kerkhofs T.M., Kerstens M.N., Kema I.P. et al. Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors. Horm Cancer 2015;6(4):168–75. DOI:10.1007/s12672-015-0224-3; Шафигуллина З.Р., Великанова Л.И., Ворохобина Н.В. и др. Диагностическое значение стероидных профилей биологических жидкостей больных синдромом Кушинга. Проблемы эндокринологии 2015;61(4):4–8. DOI:10.14341/probl20156144-8; Velikanova L.I., Shafigullina Z.R., Lisitsin A.A. et al. Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma. Horm Cancer 2016;7(56):327–35. DOI:10.1007/s12672-016-0267-0; Schweitzer S., Kunz M., Kurlbaum M. et al. Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma. Eur J Endocrinol 2019;180(2):117–25. DOI:10.1530/EJE-18-0782; Bancos I., Taylor A.E., Chortis V. et al. Urinary steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT trial: a prospective validation study. Lancet Diabetes Endocrinol 2020;8:773–81. DOI:10.1016/S2213-8587(20)30218-7; Paragliola R.M., Corsello A., Locantore P. et al. Medical approaches in adrenocortical carcinoma. Biomedicines 2020;8(12):551. DOI:10.3390/biomedicines8120551; Lam A.K. Adrenocortical carcinoma: updates of clinical and pathological features after renewed World Health Organisation classification and pathology staging. Biomedicines 2021;9(2):175. DOI:10.3390/biomedicines9020175; Terzolo M., Fassnacht M., Perotti P. et al. Results of the ADIUVO study, the first randomized trial on adjuvant mitotane in adrenocortical carcinoma patients. J Endoc Soc 2021;5(Suppl. 1): A166–7. DOI:10.1210/jendso/bvab048.336; Haluska P., Worden F., Olmos D. et al. Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma. Cancer Chemother Pharmacol 2010;65:765–73. DOI:10.1007/s00280-009-1083-9; Lerario A.M., Worden F.P., Ramm C.A. et al. The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional nci-sponsored trial. Horm Cancer 2014;5:232–9. DOI:10.1007/s12672-014-0182-1; Fassnacht M., Berruti A., Baudin E. et al. Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. Lancet Oncol 2015;16(4):426–35. DOI:10.1016/S1470-2045(15)70081-1; Kroiss M., Quinkler M. et al. Sunitinib in refractory adrenocortical carcinoma: a phase ii, single-arm, open-label trial. J Clin Endocrinol Metab 2012;97(10):3495–503. DOI:10.1210/jc.2012-1419; Berruti A., Sperone P., Ferrero A. et al. Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. Eur J Endocrinol 2012;166(3): 451–8. DOI:10.1530/EJE-11-0918; Bedrose S., Miller K.C., Altameemi L. et al. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. J Immunother Cancer 2020;8:e001009. DOI:10.1136/jitc-2020-001009; Kroiss M., Megerle F., Kurlbaum M. et al. Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib. J Clin Endocrinol Metab 2020;105(5):14618. DOI:10.1210/clinem/dgz318; O’Sullivan C., Edgerly M., Velarde M. et al. The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer. J Clin Endocrinol Metab 2014;99(4):1291–7. DOI:10.1210/jc.2013-2298; Kroiss M., Deutschbein T., Schlötelburg W. et al. Treatment of refractory adrenocortical carcinoma with thalidomide: analysis of 27 patients from the European Network for the Study of Adrenal Tumours Registry. Exp Clin Endocrinol Diabetes 2019;127(9): 578–84. DOI:10.1055/a-0747-5571; Wortmann S., Quinkler M., Ritter C. et al. Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma. Eur J Endocrinol 2010;162(2):349–56. DOI:10.1530/EJE-09-0804; Laganà M., Grisanti S., Ambrosini R. et al. Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. ESMO Open 2022;7(2):100422. DOI:10.1016/j.esmoop.2022.100422; Berruti A., Sperone P., Bellini E. et al. Metronomic therapy concepts in the management of adrenocortical carcinoma. Horm Cancer 2011;2(6):378–84. DOI:10.1007/s12672-011-0087-1; Uchihara M., Tanioka M., Kojima Y. et al. Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience. Int J Clin Oncol 2021;26(12):2275–81. DOI:10.1007/s10147-021-02021-8; Carneiro B.A., Konda B., Costa R.B. et al. Nivolumab in metastatic adrenocortical carcinoma: results of a phase 2 trial. J Clin Endocrinol Metab 2019;104:6193–200. DOI:10.1210/jc.2019-00600; Le Tourneau C., Hoimes C., Zarwan C. et al. Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the javelin solid tumor trial. J Immunother Cancer 2018;6(1):111. DOI:10.1186/s40425-018-0424-9; Alyateem G., Nilubol N. Current status and future targeted therapy in adrenocortical cancer. Front Endocrinol (Lausanne) 2021;12:613248. DOI:10.3389/fendo.2021.613248; https://umo.abvpress.ru/jour/article/view/540Test

الإتاحة: https://doi.org/10.17650/2313-805X-2023-10-2-42-57Test
https://doi.org/10.17650/2313-805X-2023-10-2Test
https://doi.org/10.1210/er.2013-1029Test
https://doi.org/10.1530/JME-18-0122Test
https://doi.org/10.1210/me.2007-01204Test
https://doi.org/10.4149/neo_2019_190105N17Test
https://doi.org/10.3390/cancers12051218Test
https://doi.org/10.3390/biomedicines9020174Test
https://doi.org/10.1016/j.mce.2011.12.006Test
https://doi.org/10.1016/j.ecl.2015.02.001Test

المؤلفون: Conde, Kristie, Fabelo, Carolina, Krause, William C, Propst, Robert, Goethel, Jordan, Fischer, Daniel, Hur, Jin, Meza, Cecilia, Ingraham, Holly A, Wagner, Edward J

المصدر: Neuroendocrinology. 105(4)

مصطلحات موضوعية: Cannabinoid Research, Neurosciences, Action Potentials, Animals, Cerebral Cortex, Endocannabinoids, Energy Intake, Enzyme Inhibitors, Estradiol, Excitatory Amino Acid Antagonists, Excitatory Postsynaptic Potentials, Female, GABA Antagonists, Glutamic Acid, Guinea Pigs, Lactones, Lipoprotein Lipase, Male, Neural Pathways, Neurons, Orlistat, Pro-Opiomelanocortin, Pyridazines, Signal Transduction, Steroidogenic Factor 1, Testosterone, Up-Regulation, Proopiomelanocortin, Diacylglycerol lipase-alpha, Depolarization-induced suppression of excitation, 2-Arachidonoylglycerol, Depolarization-induced suppression of excitation, Diacylglycerol lipase-α, Clinical Sciences, Endocrinology & Metabolism

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6nt4r16qTest

المؤلفون: Bashamboo, Anu, Donohoue, Patricia, Vilain, Eric, Rojo, Sandra, Calvel, Pierre, Seneviratne, Sumudu, Buonocore, Federica, Barseghyan, Hayk, Bingham, Nathan, Rosenfeld, Jill, Mulukutla, Surya, Jain, Mahim, Burrage, Lindsay, Dhar, Shweta, Balasubramanyam, Ashok, Lee, Brendan, Dumargne, Marie-Charlotte, Eozenou, Caroline, Suntharalingham, Jenifer, de Silva, Ksh, Lin, Lin, Bignon-Topalovic, Joelle, Poulat, Francis, Lagos, Carlos, McElreavey, Ken, Achermann, John

المصدر: Human Molecular Genetics. 25(16)

مصطلحات موضوعية: Adult, Androgen-Insensitivity Syndrome, Cell Lineage, Child, DNA-Binding Proteins, Disorder of Sex Development, 46, XY, Female, Gonads, Humans, Karyotype, Male, Mutation, Missense, Ovary, Pedigree, Primary Ovarian Insufficiency, Sex Determination Processes, Sexual Development, Steroidogenic Factor 1, Testis

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/61c4c8w9Test

المؤلفون: Ken-ichirou Morohashi, Miki Inoue, Takashi Baba

المصدر: Endocrinology and Metabolism, Vol 35, Iss 4, Pp 756-764 (2020)

مصطلحات موضوعية: nr5a1, steroidogenic factor 1, ad4bp, knockout, cell proliferation, glycolysis, gonads, adrenal glands, cell differentiation, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: http://www.e-enm.org/upload/pdf/enm-2020-402.pdfTest; https://doaj.org/toc/2093-596XTest; https://doaj.org/toc/2093-5978Test

الوصول الحر: https://doaj.org/article/f101b7d88f774c5abe6d050e64ffcd92Test